MEK4 (MAP2K4) (S257) Antibody Blocking peptide

SKU: orb1445701

Description

MEK4 (MAP2K4) (S257) Antibody Blocking peptide

Research Area

Apoptotic, Cancer, Epigenetics, Neuroscience, Signaling Pathways

Images & Validation

• Application Notes:
  Synthetic peptide

Key Properties

• Protein Sequence: The synthetic peptide sequence used to generate the antibody orb1928767 was selected from the S257 region of human MAP2K4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Storage & Handling

• Form/Appearance: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Dual specificity mitogen-activated protein kinase kinase 4, MAP kinase kinase 4, MAPKK 4, JNK-activating kinase 1, MAPK/ERK kinase 4, MEK 4, SAPK/ERK kinase 1, SEK1, Stress-activated protein kinase kinase 1, SAPK kinase 1, SAPKK-1, SAPKK1, c-Jun N-terminal kinase kinase 1, JNKK, MAP2K4, JNKK1, MEK4, MKK4, PRKMK4, SEK1, SERK1, SKK1

Quick Database Links

UniProt

P45985